All News

RheumNow Podcast square

RheumNow Podcast – BandAids for Rheumatologists (5.14.2021)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com - a website for rheumatologists, by rheumatologists.



We love Rheumatology!

Read Article
RNL, over, microphone

RheumNow Live 2021 Now Available for All

d Jack Cush, MD

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).

Read Article
masks_0.jpg

CDC: Fully Vaccinated Can Shed Masks and Resume Travel

d Jack Cush, MD

The U.S.

Read Article
ild.jpg

Risk Factors for Rheumatoid Arthritis-associated Interstitial Lung Disease

d Jack Cush, MD

Sparks and colleagues have published a matched cohort analysis demonstrating risk factors that may augment the risk of rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), especially the combination of obesity, high CRP, high MD-HAQ and >30 pack-year smoking h

Read Article
NSAIDs.pills_.caps_.jpg

NSAID Safety with COVID-19 Infection

d Jack Cush, MD

NSAIDs do not affect COVID outcomes; here we are nearly 16 months into the pandemic, and this is the common sense conclusion of a recent trial published in Lancet Rheumatology.

Read Article
cost.price_.biologic.injectable.jpg

Insurers Bet Big on Bribing Patients

d Madelaine Feldman, MD, and Jay Salliotte

Last month, psoriasis patients covered by Cigna received a curious letter from the insurance giant's pharmacy management division.

Read Article
RNL 2021: EULAR 2019 and ACR 2020 RA Treatment Guidelines - Dr. Alan Matsumoto Dr. Alan Matsumoto presents EULAR 2019 and ACR 2020 RA Treatment Guidelines at the 2021 RheumNow Live meeting. https://t.co/1swZIWGWKc

Links:

Dr. John Cush RheumNow ( View Tweet)

Cerecor has launched a c Phase 1b clinical trial (NCT04752371) of the human mAb CERC-007, targeting IL-18, in 12 patients with active adult onset Still’s disease (AOSD). They estimate AOSD affects 3,500 - 7,000 in the US 3,400 - 6,900 pts in Europe https://t.co/DlW1QbXOG0

Links:

Dr. John Cush RheumNow ( View Tweet)

CDC study from 33 sites, 25 states showed vaccine efficacy (against Sx COVID) in HCP was 82% with ONEdose (Pfizer, Moderna) and 94% for TWO doses (same as RCTs). The efficacy of only 1 dose (of a 2 dose COVID vax) is likely to be 70- 82%. https://t.co/uQhUmjSsRd

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Mike Putman - TULIP Trials - Anifrolumab in SLE https://t.co/cqZiulDMFm #LupusAwarenessMonth https://t.co/kNKLUSOKWp

Links:

Dr. John Cush RheumNow ( View Tweet)
Clinical practice data study of 855 Psoriatic arthritis patients. With no differences in treatment, women has worse disease activity score (vs M) (PASDAS 3.5 vs 2.7; p < 0.001). Higher BMI assoc w/ no reaching Low Dz activity in Women, not men. https://t.co/CVAEHhjqCH

Links:

Dr. John Cush RheumNow ( View Tweet)

Worth sharing again-- ACR Updates COVID-19 Vaccine Guidance- April 2021 The ACR COVID-19 Vaccine Clinical Guidance was originally published on 2/8/21 & updated on 3/4/21. On 4/28/21, new recommendations were added. https://t.co/BgrFxCgjRw https://t.co/O7ngEBEX6s

Links:

Dr. John Cush RheumNow ( View Tweet)
Johns Hopkins researchers suggest that treating refractory dermatomyositis with a JAK inhibitor may improve calcinosis. Based on 3 case reports, who had either NXP2 or TIF-1γ refractory DM, all improved their skin, muscle dz and calcinosis. https://t.co/P5k5y0HS6A

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Risk Factors for Rheumatoid Arthritis-associated Interstitial Lung Disease https://t.co/ps8JeRUtJf https://t.co/Sn6ykG9ZuE

Links:

Dr. John Cush RheumNow ( View Tweet)
Sulfasalazine may be in short supply. FDA shortage lists shortage with drug return in July or 4th quarter of 2021. ASHP site also notes several generic maker shortages but they suggest resolution mid-May or July https://t.co/XYyraO6Z4z https://t.co/tm50S7ov9K https://t.co/QPWIitYkpp

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Insurers Bet Big on Bribing Patients https://t.co/Tcip2xODF1 https://t.co/Ieh7yZfurk

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Janet Pope - Comorbidities in SLE From ACR 2019 https://t.co/1BjfVOfL4i https://t.co/CRqUKeYUmi

Links:

Dr. John Cush RheumNow ( View Tweet)
5 Reasons to see Rheumatologist 1. Unexplained, worsening joint or muscle pains 2. Repeated, joint pain/swelling, fevers, rashes 3. Establish early Dx to your chronic joint complaints 4. Review abnormal labs, get a treatment plan 5. Attacks of gout https://t.co/gRVtnM4i7J

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Kathryn Dao - Lupus Pearls from ACR 2019 https://t.co/JDlfjAO0xe #LupusAwarenessMonth https://t.co/1ZiZiNvYhv

Links:

Dr. John Cush RheumNow ( View Tweet)
It's #LupusAwarenessMonth --review our lupus coverage from the archives. Dr. Janet Pope - New SLE criteria and guidelines and approach to refractory Lupus patients From RWCS 2020 https://t.co/eufxObGFic https://t.co/pReB8aPHlp

Links:

Dr. John Cush RheumNow ( View Tweet)
×